Activest Wealth Management
GYRE icon

Activest Wealth Management’s Gyre Therapeutics GYRE Stock Holding History

Activest Wealth Management’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.91K Hold
533
– – ﹤0.01% 736
2026
Q2 		$3.51K Hold
533
– – ﹤0.01% 768
2026
Q1 		$3.72K Hold
533
– – ﹤0.01% 870
2025
Q4 		$3.76K Hold
533
– – ﹤0.01% 807
2025
Q3 		$3.98K Hold
533
– – ﹤0.01% 683
2025
Q2 		$3.92K Hold
533
– – ﹤0.01% 591
2025
Q1 		$4.12K Hold
533
– – ﹤0.01% 537
2024
Q4 		$6.45K Hold
533
– – ﹤0.01% 353
2024
Q3 		$6.68K Hold
533
– – ﹤0.01% 347
2024
Q2 		$6.36K Buy
+533
New +$7.31K ﹤0.01% 328

Other funds holding GYRE

SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GoalVest Advisory
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Activest Wealth Management's GYRE Position: Q3 2026 in Review

Activest Wealth Management held its Gyre Therapeutics (GYRE) position steady in Q3 2026 at 533 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Activest Wealth Management first reported a position in GYRE in Q2 2024 and has held it in 10 quarters since. The position peaked at $6.68K in Q3 2024. 7 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.

  • Activest Wealth Management held 533 shares of Gyre Therapeutics worth $3.91K as of Q3 2026.
  • Activest Wealth Management left its Gyre Therapeutics share count unchanged in Q3 2026.
  • Gyre Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #736 holding.
  • Activest Wealth Management first reported a position in Gyre Therapeutics in Q2 2024 and has held it in 10 quarters since.
  • Activest Wealth Management's Gyre Therapeutics position peaked at $6.68K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.